Finance

Lists
ENSG:NASDAQ
The Ensign Group, Inc.
$179.06
-1.36%
(-2.46) 1D
$179.06
0.00% (0.00)
After hours
Closed: Nov 2, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENSG...
Open
$181.97
High
$183.32
Low
$177.82
Mkt. cap
10.45B
Avg. vol.
369.83K
Volume
408.32K
Dividend
0.15%
Quarterly dividend
$0.07
Ex-dividend date
Sep 30, 2026
P/E ratio
26.66
52-wk high
$218.00
52-wk low
$141.58
EPS
$6.72
Beta
0.66
Shares outstanding
58.34M
No. of employees
46K
Open
$181.97
High
$183.32
Low
$177.82
Mkt. cap
10.45B
Avg. vol.
369.83K
Volume
408.32K
Dividend
0.15%
Quarterly dividend
$0.07
Ex-dividend date
Sep 30, 2026
P/E ratio
26.66
52-wk high
$218.00
52-wk low
$141.58
EPS
$6.72
Beta
0.66
Shares outstanding
58.34M
No. of employees
46K
News stories
From web sources and news partners
About The Ensign Group, Inc.
CEOBarry R. Port
Employees46K
Founded1999
Headquarters-
SectorHealth care provider
Analyst ratings
Based on 4 analysts giving stock ratings to ENSG in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for ENSG in the last 3 months.
Highest
Current $179.06
$240.00 (+34.03%)
Average
$222.50 (+24.26%)
Lowest
$210.00 (+17.28%)
Analyst
Recommendation
Action
Price target
Projected
Date
David S Macdonald
Truist Financial
Hold
Maintained
$210.00
+17.3%
10/29/2026
Unknown Analyst
Stephens
Buy
Reiterated
$225.00
+25.7%
10/29/2026
Michael Wiederhorn
Oppenheimer
Buy
Maintained
$215.00
+20.1%
10/29/2026
A.J. Rice
UBS
Buy
Maintained
$240.00
+34%
10/29/2026
Ben Hendrix
RBC Capital
Buy
Maintained
$228.00
+27.3%
07/27/2026
Last report
Oct 28, 2026
Fiscal period
Q3 2026
$2.03 / $1.97
+3.09%beat
Revenue / Est. (USD)
1.48B / 1.51B
-1.45%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.36B
1.39B
1.44B
1.48B
Cost of goods sold
1.13B
1.15B
1.19B
1.23B
Cost of revenue
1.13B
1.15B
1.19B
1.23B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
77.79M
81.19M
86.20M
88.72M
Operating expense
105.51M
109.99M
117.61M
121.37M
Total operating expenses
1.24B
1.26B
1.31B
1.35B
Operating income
123.81M
124.85M
130.14M
136.94M
Other non operating income
2.00M
-885.00K
830.00K
828.00K
EBT including unusual items
130.08M
128.57M
133.67M
140.20M
EBT excluding unusual items
130.08M
128.57M
133.67M
140.20M
Income tax expense
34.55M
28.82M
33.84M
35.81M
Effective tax rate
26.56%
22.41%
25.32%
25.55%
Other operating expenses
-
-
-
-
Net income
95.45M
99.67M
99.74M
104.26M
Net profit margin
7.02%
7.17%
6.92%
7.03%
Earnings per share
1.82
1.85
1.92
-
Interest and investment income
6.22M
6.54M
4.63M
4.72M
Interest expense
-1.96M
-1.93M
-1.93M
-2.29M
Net interest expenses
4.27M
4.60M
2.70M
2.43M
Depreciation and amortization charges
27.72M
28.80M
31.41M
32.65M
EBITDA
151.26M
153.38M
161.82M
169.58M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps